Frontlight ResearchEarly access
Liver and biliary tract cancer trials in South Korea
78 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleEffect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Where
- Busan, Chuncheon, Gwangju, Seongnam-si, Seoul
- Age
- 18 years to 64 years
- People
- 2,076 worldwide
- Run by
- Guerbet
See details and how to joinNCT04373564 - No phaseTaking peopleRepeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma
- Where
- Busan, Seoul
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Aichi Medical University
See details and how to joinNCT07235007 - Phase 2Taking peopleA Study Comparing Immunotherapy Alone Versus Immunotherapy Combined With Radiotherapy in Patients With Hepatocellular Carcinoma (HCC) With Vascular Invasion
- Where
- Goyang, Seoul
- Age
- 19 years and over
- People
- 128
- Run by
- National Cancer Center, Korea
See details and how to joinNCT06828380 - Phase 1Taking peopleA Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
- Where
- Busan, Gyeonggi-do, Seoul
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- Myeloid Therapeutics
See details and how to joinNCT06478693 - No phaseNot yet taking people in South KoreaComparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy
- Where
- Seoul
- Age
- 19 years and over
- People
- 210
- Run by
- Konkuk University Medical Center
See details and how to joinNCT06637943 - Phase 1/2Not yet taking people in South KoreaA Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer
- Where
- Seoul
- Age
- 19 years and over
- People
- 160
- Run by
- Yonsei University
See details and how to joinNCT07269158 - No phaseTaking peopleA Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE)
- Where
- Seoul
- Age
- 20 years and over
- People
- 48
- Run by
- Yonsei University
See details and how to joinNCT07252323 - Phase 2Taking peopleA Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma
- Where
- Seoul
- Age
- 20 years and over
- People
- 52
- Run by
- Yonsei University
See details and how to joinNCT07246668 - No phaseTaking peopleImmunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving Immunotherapy
- Where
- Seoul
- Age
- 19 years and over
- People
- 50
- Run by
- Asan Medical Center
See details and how to joinNCT07186010 - No phaseTaking peopleCombination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer
- Where
- Seongnam-si
- Age
- 19 years and over
- People
- 61
- Run by
- CHA University
See details and how to joinNCT06893380 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma
- Where
- Busan, Daegu, Seoul
- Age
- 18 years and over
- People
- 45
- Run by
- Rznomics, Inc.
See details and how to joinNCT06695026 - Phase 2Taking peopleProphylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC
- Where
- Seoul
- Age
- 19 years to 80 years
- People
- 44
- Run by
- Asan Medical Center
See details and how to joinNCT06819566 - No phaseNot yet taking people in South KoreaLTFU for All Cell and Gene Therapy Studies
- Where
- Seoul
- Age
- 18 years to 130 years
- People
- 64 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06194461 - No phaseTaking peopleIntraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma
- Where
- Goyang-si
- Age
- 20 years and over
- People
- 53
- Run by
- National Cancer Center, Korea
See details and how to joinNCT06168292 - No phaseTaking peopleAte-Bev Early Response Prediction Model in Advanced HCC
- Where
- Seoul
- Age
- 18 years to 80 years
- People
- 170
- Run by
- Seoul National University Hospital
See details and how to joinNCT05763277 - Phase 1/2Taking peopleSafety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma
- Where
- Seoul
- Age
- 19 years and over
- People
- 24
- Run by
- Yoon Jun Kim
See details and how to joinNCT06911255 - Phase 1/2Taking peopleStudy of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
- Where
- Seongnam, Seoul, Suwon
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- TiumBio Co., Ltd.
See details and how to joinNCT05784688 - Phase 1/2Taking peopleFirst-line Trastuzumab, Gemcitabine, Cisplatin and Nivolumab in Advanced HER2- Positive Biliary Tract Cancer: a Multicenter, Open-label, Single-arm Phase Ib/II Trial (HERBOT)
- Where
- Seoul
- Age
- 19 years and over
- People
- 44
- Run by
- Yonsei University
See details and how to joinNCT05749900 - Phase 2Taking peopleOlaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy
- Where
- Seoul
- Age
- 19 years and over
- People
- 62
- Run by
- Asan Medical Center
See details and how to joinNCT05222971 - No phaseTaking peopleComparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation
- Where
- Seoul
- Age
- 19 years and over
- People
- 350
- Run by
- Yonsei University
See details and how to joinNCT06767579 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Where
- Seoul, Suwon
- Age
- 18 years and over
- People
- 358 worldwide
- Run by
- GI Innovation, Inc.
See details and how to joinNCT05824975 - No phaseTaking peopleSafety and Efficacy of Degradable Microsphere in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
- Where
- Seoul
- Age
- 19 years to 79 years
- People
- 150
- Run by
- Next Biomedical Co., Ltd.
See details and how to joinNCT05072041 - No phaseTaking peopleAtezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma
- Where
- Yongin-si
- Age
- 19 years to 80 years
- People
- 33
- Run by
- Yonsei University
See details and how to joinNCT06595108 - No phaseTaking peopleThe Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer
- Where
- Suwon
- Age
- 19 years to 80 years
- People
- 88
- Run by
- Saint Vincent's Hospital, Korea
See details and how to joinNCT02920554 - Phase 1Taking peopleA Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma
- Where
- Seoul
- Age
- 19 years to 65 years
- People
- 50
- Run by
- Etnova Therapeutics Corp.
See details and how to joinNCT06326502